Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Bevacizumab
100%
Non-pregnant Women
100%
Vascular Endothelial Growth Factor Signaling
100%
Preeclampsia-like Syndrome
100%
Preeclampsia
75%
Vascular Endothelial Growth Factor
50%
Neuroimaging
25%
Seizure
25%
Solid Tumors
25%
Recombinant
25%
Etiology
25%
Hypertension
25%
Headache
25%
Angiogenesis
25%
San Francisco
25%
Proteinuria
25%
Central Nervous System
25%
Supportive Care
25%
Potential Biomarkers
25%
Human Studies
25%
Thrombocytopenia
25%
Avastin
25%
Genentech
25%
Placental Growth Factor (PlGF)
25%
Multisystem Disease
25%
Acute Onset
25%
Disorder-specific
25%
Endothelial Cell Proliferation
25%
Perinatal Mortality
25%
Blurred Vision
25%
Photophobia
25%
Severe Hypertension
25%
Human Pregnancy
25%
Abnormal Liver Tests
25%
Soluble Endoglin
25%
Antiangiogenic Factors
25%
Puerperium
25%
Posterior Reversible Encephalopathy Syndrome
25%
Bevacizumab Therapy
25%
Preeclampsia Pathogenesis
25%
Monoclonal IgG Antibodies
25%
Maternal Morbidity
25%
Perinatal Morbidity
25%
Soluble Fms-like Tyrosine kinase-1 (sFlt-1)
25%
Medicine and Dentistry
Vasculotropin
100%
Pre-Eclampsia
100%
Bevacizumab
100%
Diseases
33%
Hypertension
33%
Biological Marker
16%
Epileptic Seizure
16%
Solid Malignant Neoplasm
16%
Maternal Morbidity
16%
Central Nervous System
16%
Supportive Care
16%
Endothelial Cell
16%
Cell Proliferation
16%
Puerperium
16%
Protein Tyrosine Kinase
16%
Proteinuria
16%
Human Study
16%
Angiogenesis
16%
Thrombocytopenia
16%
Headache
16%
Perinatal Mortality
16%
Photophobia
16%
Blurred Vision
16%
Immunoglobulin G Antibody
16%
Liver Function Test
16%
Irritability
16%
Placental Growth Factor
16%
Antiangiogenic
16%
Posterior Reversible Encephalopathy Syndrome
16%
Angiogenic Factor
16%
Perinatal Morbidity
16%
Abnormal Laboratory Result
16%
Endoglin
16%
Etiology
16%
Pathogenesis
16%
Pharmacology, Toxicology and Pharmaceutical Science
Syndrome
100%
Bevacizumab
100%
Vasculotropin
100%
Preeclampsia
100%
Diseases
33%
Hypertension
33%
Human Study
16%
Antiangiogenic
16%
Biological Marker
16%
Solid Malignant Neoplasm
16%
Headache
16%
Protein Tyrosine Kinase
16%
Maternal Morbidity
16%
Perinatal Mortality
16%
Angiogenic Factor
16%
Immunoglobulin G Antibody
16%
Perinatal Morbidity
16%
Proteinuria
16%
Thrombocytopenia
16%
Photophobia
16%
Blurred Vision
16%
Placental Growth Factor
16%
Endoglin
16%
Posterior Reversible Encephalopathy Syndrome
16%
Etiology
16%
Pathogenesis
16%
Biochemistry, Genetics and Molecular Biology
Vascular Endothelial Growth Factor
100%
Bevacizumab
100%
Growth Factor Signaling
100%
Human Study
16%
Soluble Fms-Like Tyrosine Kinase-1
16%
Laboratory Test
16%
Puerperium
16%
Cell Proliferation
16%
Perinatal Mortality
16%
Irritability
16%
Liver Function Test
16%
Maternal Morbidity
16%
Perinatal Morbidity
16%
Angiogenesis
16%
Endoglin
16%
Thrombocytopenia
16%
Placental Growth Factor
16%
Immunology and Microbiology
Bevacizumab
100%
Vasculotropin
100%
Central Nervous System
16%
Liver Function
16%
Cell Proliferation
16%
Laboratory Test
16%
Maternal Morbidity
16%
Immunoglobulin G Antibody
16%
Angiogenic Factor
16%
Puerperium
16%
Irritability
16%
Perinatal Morbidity
16%
Perinatal Mortality
16%
Angiogenesis
16%
Placental Growth Factor
16%
Endoglin
16%
Tyrosine
16%
Kinase
16%
Phosphotransferase
16%
Endothelial Cells
16%